Insider sales are economically immaterial (0.04% of market cap) and clustered just after a positive earnings report — likely liquidity-driven as blackout windows reopen. The COO's $128K sale is the largest, but still dwarfed by $283.7M cash and the $178.2M PRV gain. No bearish signal here; the earnings-fueled bull case (Danon Phase 2 data, extended runway) remains intact. Monitor for any 10b5-1 plan adoption by insiders or follow-on sales exceeding 0.5% of market cap before adjusting stance.
Price Chart
Executive Summary
Four Rocket Pharmaceuticals insiders, including CEO Gaurav Shah and COO Christopher Stevens, sold a total of $164K in open-market sales over the past week. This cluster comes just 10 days after Q2 earnings that showed a GAAP net income of $123.2M, driven by a $178.2M PRV sale, extended cash runway into Q2 2028, and positive Danon disease Phase 2 data. However, sales are modest relative to the $401M market cap (0.04%), and the post-earnings timing aligns with a typical blackout-window opening — reducing informational significance per academic literature on cluster sells.
Key Financial Metrics
Key Facts
- CEO Gaurav Shah sold 2,293 shares at $3.381 for ~$8K on 2026-08-18.
- COO Christopher Stevens sold 36.7K shares at $3.50 for $128K on 2026-08-11.
- Total insider sales of $164K represent ~0.04% of the $401M market cap — below the 0.1% materiality threshold.
- Cluster occurred 10 days after a bullish Q2 earnings 8-K (GAAP net income $123.2M vs. $68.9M loss YoY, cash runway extended to Q2 2028).
- All four sales are open-market (code S) — no 10b5-1 plan data provided, but post-earnings timing is consistent with routine blackout-window opening.
- Historical performance on RCKT reports shows mixed T+20 outcomes (57% win rate, avg alpha +4.65%) but no strong bias on insider reads.
Financial Impact
Total insider sales of $164K — 0.04% of market cap. Trivial relative to $401M valuation and $283.7M cash position.
Risk Factors
- Insider sales cluster post-earnings may still unsettle retail holders given RCKT's 55% analyst bullish rating but $401M depressed market cap.
- If COO Stevens continues selling larger blocks in subsequent weeks, the pattern could shift from routine to concerning.
- No 10b5-1 plan disclosure — lack of formal trading plan increases uncertainty about intent.
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 1 SEC document filed with EDGAR.
| Document | Accession Number |
|---|---|
| CLUSTER Data (Synthetic) | cluster-RCKT-1787292248070 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Sep 15, 2026 17d ago | 8-K | $3.41 $3.35 | ▼ −1.76% | ▼ −3.89% | $2.56 (−24.93%) |
Aug 20, 2026 6w ago | Insider Cluster | $3.48 $3.62 | ▲ +4.02% | ▲ +2.91% | $2.56 (−26.44%) |
Aug 17, 2026 6w ago | Insider Cluster | $3.34 $3.78 | ▲ +13.17% | ▲ +13.37% | $2.56 (−23.35%) |
Aug 13, 2026 7w ago | Insider Cluster | $3.34 $3.48 | ▲ +4.04% | ▲ +6.01% | $2.56 (−23.35%) |
Aug 10, 2026 7w ago | 8-K | $3.50 $3.34 | ▼ −4.57% | ▼ −4.17% | $2.56 (−26.86%) |
Aug 3, 2026 8w ago | 8-K | $3.41 $3.64 | ▲ +6.74% | ▲ +4.72% | $2.56 (−24.93%) |
Jun 30, 2026 13w ago | 8-K | $3.52 $4.07 | ▲ +15.63% | ▲ +15.36% | $2.56 (−27.27%) |
Jun 12, 2026 16w ago | 8-K | $2.75 $3.35 | ▲ +21.82% | ▲ +21.15% | $2.56 (−6.91%) |
May 26, 2026 18w ago | Insider Cluster | $2.99 $2.92 | ▼ −2.34% | ▼ −2.81% | $2.56 (−14.38%) |
May 7, 2026 21w ago | Insider Cluster | $3.25 $2.96 | ▼ −8.92% | ▼ −9.89% | $2.56 (−21.23%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access